Camelot Portfolios LLC purchased a new position in shares of Tempus AI, Inc. (NASDAQ:TEM - Free Report) during the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm purchased 19,606 shares of the company's stock, valued at approximately $1,246,000.
Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. ORG Partners LLC boosted its holdings in shares of Tempus AI by 2,853.3% in the 2nd quarter. ORG Partners LLC now owns 886 shares of the company's stock valued at $53,000 after buying an additional 856 shares during the period. Dakota Wealth Management boosted its holdings in shares of Tempus AI by 67.8% during the 2nd quarter. Dakota Wealth Management now owns 54,572 shares of the company's stock worth $3,467,000 after buying an additional 22,056 shares during the period. Public Employees Retirement System of Ohio bought a new position in shares of Tempus AI during the 2nd quarter worth about $2,740,000. James J. Burns & Company LLC increased its position in shares of Tempus AI by 16.7% during the 2nd quarter. James J. Burns & Company LLC now owns 14,000 shares of the company's stock worth $890,000 after purchasing an additional 2,000 shares in the last quarter. Finally, Bouvel Investment Partners LLC acquired a new stake in shares of Tempus AI during the 2nd quarter worth approximately $2,537,000. Hedge funds and other institutional investors own 24.22% of the company's stock.
Insider Transactions at Tempus AI
In other news, EVP Erik Phelps sold 3,664 shares of Tempus AI stock in a transaction that occurred on Tuesday, August 19th. The shares were sold at an average price of $74.65, for a total transaction of $273,517.60. Following the completion of the sale, the executive vice president directly owned 94,115 shares in the company, valued at approximately $7,025,684.75. This trade represents a 3.75% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CAO Ryan M. Bartolucci sold 1,904 shares of the stock in a transaction on Tuesday, August 19th. The stock was sold at an average price of $74.65, for a total value of $142,133.60. Following the completion of the transaction, the chief accounting officer directly owned 45,895 shares in the company, valued at $3,426,061.75. This trade represents a 3.98% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 601,787 shares of company stock valued at $42,492,268 over the last 90 days. Insiders own 26.27% of the company's stock.
Tempus AI Trading Up 1.5%
Shares of NASDAQ:TEM opened at $78.48 on Friday. Tempus AI, Inc. has a 12-month low of $31.36 and a 12-month high of $97.79. The business's fifty day simple moving average is $72.65 and its 200-day simple moving average is $61.93. The company has a current ratio of 1.54, a quick ratio of 1.43 and a debt-to-equity ratio of 2.58. The company has a market capitalization of $13.63 billion, a PE ratio of -65.95 and a beta of 5.08.
Tempus AI (NASDAQ:TEM - Get Free Report) last announced its quarterly earnings results on Friday, August 8th. The company reported ($0.22) earnings per share for the quarter, beating the consensus estimate of ($0.23) by $0.01. Tempus AI had a negative return on equity of 122.86% and a negative net margin of 20.98%.The firm had revenue of $314.64 million during the quarter, compared to analyst estimates of $296.84 million. During the same quarter in the previous year, the business earned ($6.86) EPS. Tempus AI's revenue for the quarter was up 89.5% compared to the same quarter last year. Tempus AI has set its FY 2025 guidance at EPS. As a group, equities research analysts predict that Tempus AI, Inc. will post -6.15 earnings per share for the current fiscal year.
Wall Street Analysts Forecast Growth
A number of brokerages recently weighed in on TEM. Morgan Stanley boosted their target price on shares of Tempus AI from $65.00 to $68.00 and gave the stock an "overweight" rating in a report on Tuesday, August 12th. HC Wainwright increased their target price on Tempus AI from $90.00 to $98.00 and gave the stock a "buy" rating in a report on Friday, September 12th. Bank of America lifted their price objective on Tempus AI from $68.00 to $70.00 and gave the stock a "neutral" rating in a report on Wednesday, June 25th. BTIG Research lifted their price target on Tempus AI from $75.00 to $85.00 and gave the company a "buy" rating in a research report on Wednesday, August 20th. Finally, Guggenheim boosted their target price on Tempus AI from $80.00 to $95.00 and gave the company a "buy" rating in a research note on Friday. Seven investment analysts have rated the stock with a Buy rating and six have given a Hold rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and a consensus price target of $71.83.
Get Our Latest Report on TEM
Tempus AI Profile
(
Free Report)
Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.
Featured Articles
Want to see what other hedge funds are holding TEM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Tempus AI, Inc. (NASDAQ:TEM - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Tempus AI, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Tempus AI wasn't on the list.
While Tempus AI currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.